Balyasny Asset Management’s Teladoc Health TDOC Stock Holding History

Balyasny Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$788K	Hold	144,600	–	–	﹤0.01%	2178
2025 Q4	$1.01M	Hold	144,600	–	–	﹤0.01%	2192
2025 Q3	$1.12M	Sell	144,600 -5,400	-4%	-$42.1K	﹤0.01%	2068
2025 Q2	$1.31M	Buy	+150,000	New	+$1.09M	﹤0.01%	1938
2023 Q1	–	Sell	-59,500	Closed	-$1.41M	–	3143
2022 Q4	$1.41M	Buy	+59,500	New	+$1.6M	﹤0.01%	1551
2020 Q4	–	Sell	-40,000	Closed	-$8.77M	–	1690
2020 Q3	$8.77M	Buy	+40,000	New	+$8.47M	0.06%	425

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's TDOC Position: Q1 2026 in Review

Balyasny Asset Management increased its Teladoc Health (TDOC) stake by 48% in Q1 2026, buying an estimated $159K and bringing the position to 86,638 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Balyasny Asset Management first reported a position in TDOC in Q2 2018 and has held it in 22 quarters since. The position peaked at $43.2M in Q2 2023. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Balyasny Asset Management held 86,638 shares of Teladoc Health worth $472K as of Q1 2026.
Balyasny Asset Management bought 28,268 Teladoc Health shares in Q1 2026, an estimated $159K.
Teladoc Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2393 holding.
Balyasny Asset Management first reported a position in Teladoc Health in Q2 2018 and has held it in 22 quarters since.
Balyasny Asset Management's Teladoc Health position peaked at $43.2M in Q2 2023.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.